SEC filing intelligence for serious investors.
Filign turns SEC filings into evidence-backed research: what changed, why it matters, whether the financials confirm it, and where the source evidence appears.
Educational research tool. Filign does not provide financial advice, price targets, predictions, or buy/sell recommendations.
The Filign thesis
Filing-first research starts with what companies are required to disclose.
SEC filings often reveal changes in risk language, liquidity discussion, legal exposure, share count, and management tone. Filign is built to turn those public disclosures into a cleaner research workflow: compare the filing, classify the change, check the numbers, and show the evidence.
What Filign covers
A research desk built around filing evidence.
The goal is not to predict the stock. The goal is to show what changed in the company's disclosures, whether the financials support the change, and which source evidence deserves deeper review.
Research workflow
From ticker to source-backed research room.
Filign keeps the workflow narrow and explainable. It starts with SEC data, not market narratives, and builds the report from comparison, financial context, and source evidence.
Built for serious DD
For investors who read the filing before the headline.
Filign is built for people who want sourced research, not generic summaries. The platform is filing-first by design.